NCT06229236

Assessing Effectiveness of a Diabetes Navigator in Increasing Progression of Advanced Diabetes Technologies

Name: Clinical Trial NCT06229236
Creator: Johns Hopkins University
Keywords: Diabetes Mellitus, Type 1, Diabetes Navigator, behavioral, clinical trial, United States of America

Assessing Effectiveness of a Diabetes Navigator in Increasing Progression (Improving Uptake and/or Optimization) of Advanced Diabetes Technologies

Johns Hopkins University·ClinicalTrials.gov·behavioralRecruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Diabetes Mellitus, Type 1
Drug/Device/Intervention: Diabetes Navigator
Study type: Interventional
Intervention type: behavioral

Sponsor & location

Primary sponsor: Johns Hopkins University
Location: Baltimore, United States of America

Timeline & enrollment

Phase: N/A
Start date: Feb 13, 2024
End date: Jun 30, 2026
Enrollment: 148 participants

Primary outcome

Percent of participants whose Diabetes Technology Utilization Score (DTUS) increases (based on review of last 14 days of CGM and insulin pump data)

Summary

The goal of this randomized control trial is to determine if the support of a Diabetes Navigator is more effective than standard care in improving uptake and use of advanced diabetes technology among patients with type 1 diabetes.

ICD-10 classifications

Type 1 diabetes mellitusType 1 diabetes mellitus with unspecified complicationsType 1 diabetes mellitus with other specified complicationsType 1 diabetes mellitus without complicationsType 1 diabetes mellitus with multiple complications

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06229236
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06229236 through Pure Global AI's free database. This phase not specified trial is sponsored by Johns Hopkins University and is currently Recruiting. The study focuses on Diabetes Mellitus, Type 1. Target enrollment is 148 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.